Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$100,433,885
-$10,624,725 QoQ
Shares Held
108,253
-28.8% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#40
of 504 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LORD, ABBETT & CO. LLC holds $1,234,584,311 across 31 Biotechnology names. ARGX ranks #4 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
281,500 | $151,151,425 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
789,241 | $147,809,054 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
3,431,030 | $132,780,861 | |
| 4 | ARGX |
Argenx SE
This page
|
108,253 | $100,433,885 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
166,581 | $82,745,780 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
540,977 | $63,332,177 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
398,994 | $48,908,684 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
590,074 | $48,132,336 |
All Filings in ARGX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,433,885 | 108,253 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $111,058,610 | 152,083 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $171,439,430 | 203,864 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $145,208,600 | 196,877 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $55,716,766 | 101,079 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $162,585,315 | 274,700 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $126,814,230 | 206,202 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $88,338,983 | 162,963 | Shares | Sole | 2024-12-13 | |
| 2023-09-30 | $155,541,899 | 316,380 | Shares | Other | 2024-10-07 | |
| 2023-06-30 | $69,903,531 | 179,364 | Shares | Sole | 2024-10-07 | |
| 2023-03-31 | $49,066,177 | 131,693 | Shares | Sole | 2024-10-07 | |
| 2022-12-31 | $54,924,667 | 144,985 | Shares | Sole | 2024-10-07 | |
| 2022-09-30 | $132,688,546 | 375,835 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $110,917,498 | 292,751 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $8,508,009 | 26,983 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,802,025 | 25,135 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,843,320 | 22,660 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $6,489,262 | 21,554 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $4,734,504 | 17,192 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $65,403,556 | 222,393 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $58,287,315 | 222,030 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $64,187,622 | 284,987 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $44,264,836 | 336,027 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||